Peritoneal Fluid Reduces Angiogenesis-Related MicroRNA Expression in Cell Cultures of Endometrial and Endometriotic Tissues from Women with Endometriosis

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Braza Boïls, Aitana ^a   Gilabert Estellés, Juan ^b   Ramón, Luis A ^a   Gilabert, Juan ^c   Marí Alexandre, Josep ^a   Chirivella, Melitina ^a   España, Francisco ^a   Estellés, Amparo ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; MICRORNA 125A; MICRORNA 16; MICRORNA 17 5P; MICRORNA 20A; MICRORNA 221; MICRORNA 222; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOSPONDIN 1; UNCLASSIFIED DRUG; UROKINASE; VASCULOTROPIN A;

ADULT; ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; ENDOMETRIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PERITONEAL FLUID; PLASMINOGEN ACTIVATOR INHIBITOR 1 GENE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOSPONDIN 1 GENE; UROKINASE GENE; VASCULOTROPIN A GENE;

ADULT; ASCITIC FLUID; CELL CULTURE TECHNIQUES; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; FIBRINOLYSIS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMAL CELLS; THROMBOSPONDIN 1; UROKINASE-TYPE PLASMINOGEN ACTIVATOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 84876434683     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062370     Document Type: Article

References (79)

1. Burney RO, Giudice LC, (2012) Pathogenesis and pathophysiology of endometriosis. Fertil Steril 98: 511-9.
2. Giudice LC, Kao LC, (2004) Endometriosis. Lancet 364: 1789-1799.
3. Bulun SE, (2009) Endometriosis. N Engl J Med 360: 268-279.
4. Sampson JA, (1927) Peritoneal endometriosis due to menstrual dissemination of endometrial tissues into the peritoneal cavity. Am J Obstet Gynecol 14: 422-469.
5. Hapangama DK, Raju RS, Valentijn AJ, Barraclough D, Hart A, et al. (2012) Aberrant expression of metastasis-inducing proteins in ectopic and matched eutopic endometrium of women with endometriosis: implications for the pathogenesis of endometriosis. Hum Reprod 27: 394-407.
6. Laschke MW, Menger MD, (2007) In vitro and in vivo approaches to study angiogenesis in the pathophysiology and therapy of endometriosis. Hum Reprod Update 13: 331-342.
7. Kobayashi H, (2000) Invasive capacity of heterotopic endometrium. Gynecol Obstet Invest 50 (Suppl):: 26-32.
8. Zondervan KT, Treloar SA, Lin J, Weeks DE, Nyholt DR, et al. (2007) Significant evidence of one or more susceptibility loci for endometriosis with near-Mendelian inheritance on chromosome 7p13-15. Hum Reprod 22: 717-728.
9. Cosín R, Gilabert-Estellés J, Ramón LA, Gómez-Lechón MJ, Gilabert J, et al. (2010) Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis. Hum Reprod 25: 398-405.
10. Koninckx PR, Kennedy SH, Barlow DH, (1998) Endometriotic disease: the role of peritoneal fluid. Hum Reprod Update 4: 741-751.
11. Mier-Cabrera J, Jiménez-Zamudio L, García-Latorre E, Cruz-Orozco O, Hernández-Guerrero C, (2011) Quantitative and qualitative peritoneal immune profiles, T-cell apoptosis and oxidative stress-associated characteristics in women with minimal and mild endometriosis. BJOG 118: 6-16.
12. Na YJ, Lee DH, Kim SC, Joo JK, Wang JW, et al. (2010) Effects of peritoneal fluid from endometriosis patients on the release of monocyte-specific chemokines by leukocytes. Arch Gynecol Obstet 283: 1333-1341.
13. Liu Y, Hu J, Shen W, Wang J, Chen C, et al. (2011) Peritoneal fluid of patients with endometriosis promotes proliferation of endometrial stromal cells and induces COX-2 expression. Fertil Steril 95: 1836-1838.
14. Minici F, Tiberi F, Tropea A, Orlando M, Gangale MF, et al. (2008) Endometriosis and human infertility: a new investigation into the role of eutopic endometrium. Hum Reprod 23: 530-537.
15. McLaren J, (2000) Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update 6: 45-55.
16. Laschke MW, Elitzsch A, Vollmar B, Vajkoczy P, Menger MD, (2006) Combined inhibition of vascular endothelial growth factor (VEGF), fibroblast growth factor and platelet-derived growth factor, but not inhibition of VEGF alone, effectively suppresses angiogenesis and vessel maturation in endometriotic lesions. Hum Reprod 21: 262-268.
17. Laschke MW, Giebels C, Menger MD, (2011) Vasculogenesis: a new piece of the endometriosis puzzle. Hum Reprod Update 17: 628-636.
18. Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M, (1998) Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 13: 1686-1690.
19. Fasciani A, D'Ambrogio G, Bocci G, Monti M, Genazzani AR, et al. (2000) High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometrioma. Mol Hum Reprod 6: 50-54.
20. McLaren J, Prentice A, Charnock-Jones DS, Smith SK, (1996) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum Reprod 11: 220-223.
21. Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, et al. (2004) Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol 35: 1369-1375.
22. Girling JE, Rogers PA, (2005) Recent advances in endometrial angiogenesis research. Angiogenesis 8: 89-99.
23. Gilabert-Estellés J, Ramón LA, España F, Gilabert J, Vila V, et al. (2007) Expression of angiogenic factors in endometriosis: its relation to fibrinolytic and metalloproteinase (MMP) systems. Hum Reprod 22: 2120-2127.
24. Tan XJ, Lang JH, Liu DY, Shen K, Leng JH, et al. (2002) Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril 78: 148-153.
25. Kawano Y, Nakamura S, Nasu K, Fukuda J, Narahara H, et al. (2005) Expression and regulation of thrombospondin-1 by human endometrial stromal cells. Fertil Steril 83: 1056-1059.
26. Fish JE, Srivastava D, (2009) MicroRNAs: opening a new vein in angiogenesis research. Sci Signal 2: pe1 doi:10.1126/scisignal.252pe1.
27. Suarez Y, Sessa WC, (2009) MicroRNAs as novel regulators of angiogenesis. Circ Res 104: 442-454.
28. Wu F, Yang Z, Li G, (2009) Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 386: 549-553.
29. Wang S, Olson EN, (2009) AngiomiRs-key regulators of angiogenesis. Curr Opin Genet Dev 19: 205-211.
30. Caporali A, Emanueli C, (2011) MicroRNA regulation in angiogenesis. Vascul Pharmacol 55: 79-86.
31. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
32. Ohlsson-Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, et al. (2009) MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 23: 265-275.
33. Ambros V, (2004) The functions of animal microRNAs. Nature 16 431: 350-355.
34. Burney RO, Hamilton AE, Aghajanova L, Vo KC, Nezhat CN, et al. (2009) MicroRNA expression profiling of eutopic secretory endometrium in women with versus without endometriosis. Mol Hum Reprod 15: 625-631.
35. Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, et al. (2010) Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium. Biol Reprod 82: 791-801.
36. Ramón LA, Braza-Boïls A, Gilabert J, España F, Chirivella M, et al. (2012) microRNAs related to angiogenesis are dysregulated in endometriod endometrial cancer. Human Reprod 27: 3036-3045.
37. Sonkoly E, Pivarcsi A, (2009) microRNAs in inflammation. Int Rev Immunol 28: 535-561.
38. Wittmann J, Jäck HM, (2010) Serum microRNAs as powerful cancer biomarkers. Biochim Biophys Acta 1806: 200-207.
39. Gilabert-Estellés J, Braza-Boïls A, Ramón LA, Zorio E, Medina P, et al. (2012) Role of microRNAs in gynecological pathology. Curr Med Chem 19: 2406-2413.
40. Guo SW, (2009) Epigenetics of endometriosis. Mol Hum Reprod 15: 587-607.
41. Aghajanova L, Giudice LC, (2011) Molecular evidence for differences in endometrium in severe versus mild endometriosis. Reprod Sci 18: 229-251.
42. Pan Q, Luo X, Toloubeydokhti T, Chegini N, (2007) The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 13: 797-806.
43. Pan Q, Chegini N, (2008) MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 26: 479-493.
44. Ohlsson-Teague EM, Print CG, Hull ML, (2010) The role of microRNAs in endometriosis and associated reproductive conditions. Hum Reprod Update 16: 146-165.
45. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, et al. (2011) Functional microRNA involved in endometriosis. Mol Endocrinol 25: 821-832.
46. Ramón LA, Braza-Boïls A, Gilabert-Estellés J, Gilabert J, España F, et al. (2011) microRNAs expression in endometriosis: its relation to angiogenic factors. Human Reprod 26: 1082-1090.
47. Urbich C, Kuehbacher A, Dimmeler S, (2008) Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 79: 581-588.
48. Chamorro-Jorganes A, Araldi E, Penalva LO, Sandhu D, Fernández-Hernando C, et al. (2011) MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1. ArteriosclerThromb Vasc Biol 31: 2595-2606.
49. Yang W, Lee DY, Ben-David Y, (2011) The roles of microRNAs in tumorigenesis and angiogenesis. Int J Physiol Pathophysiol Pharmacol 3: 140-155.
50. Patella F, Rainaldi G, (2011) MicroRNAs mediate metabolic stresses and angiogenesis. Cell Mol Life Sci 69: 1049-1065.
51. American Society for Reproductive Medicine (1997) Revised American Society for Reproductive Medicine Classification of endometriosis. Fertil Steril 67: 817-821.
52. Hirota Y, Osuga Y, Koga K, Yoshino O, Hirata T, et al. (2005) Possible implication of midkine in the development of endometriosis. Hum Reprod 20: 1084-1089.
53. Ramón L, Gilabert-Estellés J, Castelló R, Gilabert J, España F, et al. (2005) mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay. Hum Reprod 20: 272-278.
54. Gilabert-Estellés J, Estellés A, Gilabert J, Castelló R, España F, et al. (2003) Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis. Hum Reprod 18: 1516-1522.
55. Cho S, Choi YS, Jeon YE, Im KJ, Choi YM, et al. (2012) Expression of vascular endothelial growth factor (VEGF) and its soluble receptor-1 in endometriosis. Microvasc Res 83: 237-242.
56. Velasco I, Acién P, Campos A, Acién MI, Ruiz-Maciá E, (2010) Interleukin-6 and other soluble factors in peritoneal fluid and endometriomas and their relation to pain and aromatase expression. J Reprod Immunol 84: 199-205.
57. Michaud N, Al-Akoum M, Gagnon G, Girard K, Blanchet P, et al. (2011) Decreased concentrations of soluble interleukin-1 receptor accessory protein levels in the peritoneal fluid of women with endometriosis. J Reprod Immunol 92: 68-73.
58. McKinnon B, Bersinger NA, Wotzkow C, Mueller MD, (2012) Endometriosis-associated nerve fibers, peritoneal fluid cytokine concentrations, and pain in endometriotic lesions from different locations. Fertil Steril 97: 373-380.
59. Drosdzol-Cop A, Skrzypulec-Plinta V, Stojko R, (2012) Serum and peritoneal fluid immunological markers in adolescent girls with chronic pelvic pain. Obstet Gynecol Surv 67: 374-381.
60. Carvalho LF, Abrão MS, Biscotti C, Sharma R, Nutter B, et al. (2013) Oxidative Cell Injury as a Predictor of Endometriosis Progression. Reprod Sci. doi:10.1177/1933719112466301.
61. Ng EK, Wong CL, Ma ES, Kwong A, (2009) MicroRNAs as new Players for diagnosis, prognosis, and therapeutic targets in breast cancer. J Oncol 2009: 1-6.
62. Zorio E, Medina P, Rueda J, Millán JM, Arnau MA, et al. (2009) Insights of the role of microRNAs in cardiac diseases: from biological signaling to therapeutic targets. Cardiovas Hematol Agent Med Chem 7: 82-90.
63. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, et al. (2008) Serum microRNAs are promising novel biomarkers. PLoS One 3: e3148.
64. Reid G, Kirschner MB, van Zandwijk N, (2011) Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 80: 193-208.
65. Qin B, Yang H, Xiao B, (2012) Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep 39: 4509-4518.
66. Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, et al. (2010) Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. Blood 115: 4944-4950.
67. Mendell JT, (2008) miRiad roles for the miR-17-92 cluster in development and disease. Cell 133: 217-322.
68. Dews M, Homayouni A, Yu D, Murphy D, Sevignani C, et al. (2006) Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nat Genet 38: 1060-1065.
69. Suárez Y, Fernández-Hernando C, Yu J, Gerber SA, Harrison KD, et al. (2008) Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 105: 14082-14087.
70. Hua Z, Lv Q, Ye W, Wong CK, Cai G, et al. (2006) MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 1: e116.
71. Poliseno L, Tuccoli A, Mariani L, Evangelista M, Citti L, et al. (2006) MicroRNAs modulate the angiogenic properties of HUVECs. Blood 108: 3068-3071.
72. Wu F, Yang Z, Li G, (2009) Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun 386: 549-553.
73. Li Y, Song YH, Li F, Yang T, Lu YW, et al. (2009) MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun 381: 81-83.
74. Sacco K, Portelli M, Pollacco J, Schembri-Wismayer P, Calleja-Agius J, (2012) The role of prostaglandin E(2) in endometriosis. Gynecol Endocrinol 28: 134-138.
75. Pepper MS, (2001) Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21: 1104-1107.
76. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, et al. (2008) Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 15: 923-929.
77. Gilabert-Estelles J, Castello R, Gilabert J, Ramon LA, España F, et al. (2005) Plasminogen activators and plasminogen activator inhibitors in endometriosis. Front Biosci 10: 1162-1176.
78. Osteen KG, Bruner KL, Sharpe-Timms KL, (1996) Steroid and growth factor regulation of matrix metalloproteinase expression and endometriosis. Semin Reprod Endocrinol 14: 247-255.
79. Sillem M, Prifti S, Koch A, Neher M, Jauckus J, et al. (2001) Regulation of matrix metalloproteinases and their inhibitors in uterine endometrial cells of patients with and without endometriosis. Eur J Obstet Gynecol Reprod Biol 95: 167-174.